The database
Compounds
126 compounds and 6 stacks, grouped by what people use them for. Every page cites its sources.
- Stacks6
- Fat loss34
- Muscle & growth hormone17
- Tendon & gut repair6
- Skin & hair22
- Mind & sleep16
- Brain & nerves6
- Hormones & libido13
- Longevity20
- Immune10
Stacks 6
- Mind & sleepUpdated Sep 28Flow StateThe focus-and-sleep stack for when Adderall isn't an option. Trials of the three together: zero.Evidence · No dataNot legal to compound
- Muscle & growth hormoneUpdated Sep 28GH StackThe growth-hormone pair peptide clinics prescribe most. Trials of the pair itself: zero.Evidence · No dataNot legal to compound
- Skin & hairUpdated Sep 28GLOW StackWolverine plus a copper peptide, sold for skin, scars and hair. Human trials of the three together: zero.Evidence · No dataNot legal to compound
- Tendon & gut repairUpdated Sep 28KLOW StackGLOW with an anti-inflammatory peptide added, run as one 80 mg vial. Human trials of the four together: zero.Evidence · No dataNot legal to compound
- LongevityUpdated Sep 28Mito StackSold as software, hardware and fuel for tired mitochondria. Trials of the three together: zero.Evidence · No dataNot legal to compound
- Tendon & gut repairUpdated Sep 29Wolverine StackThe most-run recovery stack: BPC-157 plus TB-500. Human trials of the pair: zero, after about 15 years.Evidence · Animal onlyNot legal to compound
Fat loss 34
- Fat lossUpdated Sep 29LiraglutideThe daily shot before Ozempic, approved for kids as young as six. Its main trial: 8% weight loss at 56 weeks.Evidence · Approved drugFDA approved
- Fat lossUpdated Sep 28OrforglipronFoundayo: a daily weight-loss pill with no fasting rules. Phase 3: 11.2% weight loss at 72 weeks.Evidence · Approved drugFDA approved
- Fat lossUpdated Sep 29SemaglutideThe weekly shot the FDA approved as Ozempic and Wegovy. Weight loss in its main trial: 14.9%, on average.Evidence · Approved drugFDA approved
- Fat lossUpdated Sep 28SetmelanotideFor rare genetic obesity, not everyday weight loss. Phase 3: 8 of 10 patients lost at least 10% in a year.Evidence · Approved drugFDA approved
- Muscle & growth hormoneUpdated Sep 29TesamorelinApproved for HIV-related belly fat; clinics use it off-label. Its 412-patient trial cut belly fat 15–18%.Evidence · Approved drugFDA approved
- Fat lossUpdated Sep 29TirzepatideZepbound: the weekly shot that beat semaglutide head-to-head. Main trial: 20.9% weight loss at 72 weeks.Evidence · Approved drugFDA approved
- Fat lossUpdated Sep 29AmycretinNovo's next weight-loss shot and pill, trials only. Every published result: Novo-funded trials, 759 people.Evidence · Human trialsResearch only
- Fat lossUpdated Sep 28AOD-9604Sold as growth hormone's fat-burning fragment. Its biggest trial, 536 people over 24 weeks, missed its goal.Evidence · Human trialsResearch only
- Fat lossUpdated Sep 29BimagrumabPitched as fat loss that keeps muscle. Alone, it took off less weight than semaglutide in a 507-adult trial.Evidence · Human trialsResearch only
- Fat lossUpdated Sep 29CagrilintideThe other half of Novo's CagriSema combo. Alone it's gray-market; paired, 20.4% weight loss at 68 weeks.Evidence · Human trialsResearch only
- Fat lossUpdated Sep 29CagriSemaNovo's two-drug shot built to beat Zepbound. 20.4% weight loss in Phase 3; the FDA hasn't ruled yet.Evidence · Human trialsResearch only
- Fat lossUpdated Sep 29DulaglutideTrulicity: a weekly diabetes shot, not a weight-loss drug. Typical loss: 2–5 kg.Evidence · Human trialsFDA approved
- Fat lossUpdated Sep 29EcnoglutideChina's weekly weight-loss shot, billed as beating semaglutide. The proof: a conference poster at week 20.Evidence · Human trialsResearch only
- Fat lossUpdated Sep 29EloralintideLilly's next weight-loss shot, in trials only. Phase 2: 20% weight loss at 48 weeks in 263 adults.Evidence · Human trialsResearch only
- Fat lossUpdated Sep 29MariTideAmgen's bid for a once-a-month obesity shot. In print so far: one efficacy trial, 592 people, Amgen-funded.Evidence · Human trialsResearch only
- Fat lossUpdated Sep 29MazdutidePrescribed in China since 2025; not approved in the US. Main trial: 14.4% weight loss at 32 weeks.Evidence · Human trialsResearch only
- Fat lossUpdated Sep 28PemvidutideAltimmune's two-in-one weight-loss shot, in trials only. Phase 2: 15.6% loss at 48 weeks in 391 adults.Evidence · Human trialsResearch only
- Fat lossUpdated Sep 29PramlintideApproved in 2005 for diabetics on insulin: three shots a day, boxed warning. Not a weight-loss drug.Evidence · Human trialsFDA approved
- Fat lossUpdated Sep 29RetatrutideLilly's triple-hormone shot, trials only; gray-market copies sell anyway. Phase 2: 24.2% loss at 48 weeks.Evidence · Human trialsResearch only
- Fat lossUpdated Sep 28SurvodutideBoehringer's two-in-one weight-loss shot, in Phase 3. Phase 2 beat placebo by up to 12 points of body weight.Evidence · Human trialsResearch only
- Fat lossUpdated Sep 28TesofensineBack on the gray market since the weight-loss-shot shortages. Phase 2: 9.2% loss in 24 weeks; no Phase 3.Evidence · Human trialsResearch only
- Fat lossUpdated Sep 28VK2735Viking's rival to Mounjaro, in trials only. Phase 2: 14.7% weight loss in 13 weeks at the top dose.Evidence · Human trialsResearch only
- Fat lossUpdated Sep 29CardarineTaken as an exercise pill for fat loss. Its maker quit after 2-year rodent tests found tumors at every dose.Tumors in rats and mice at every doseEvidence · Human pilotsResearch only
- Fat lossUpdated Sep 29GlumitideLilly's trial-only shot, built from one half of Zepbound. Data: two Phase 1 studies, four weeks of dosing.Evidence · Human pilotsResearch only
- Fat lossUpdated Sep 29PetrelintidePitched as the weight-loss shot you can stay on. The 10.7% result is company-reported; no paper yet.Evidence · Human pilotsResearch only
- Fat lossUpdated Sep 285-Amino-1MQSold as a fat-loss pill for a stubborn metabolism. Every result so far: obese mice, from one lab.Evidence · Animal onlyResearch only
- Fat lossUpdated Sep 28AdipotidePitched as a way to starve fat cells of blood. Obese monkeys lost 11% of their fat; their kidneys objected.Kidney damage in primate trialsEvidence · Animal onlyResearch only
- Fat lossUpdated Sep 29AICARSold as exercise in a pill. The 2008 mice ran 44% farther; no human trial has matched it.Evidence · Animal onlyResearch only
- Fat lossUpdated Sep 29GW-0742Sold as a 'cleaner Cardarine' for endurance and fat loss. Human studies: zero; it never entered trials.Evidence · Animal onlyResearch only
- Fat lossUpdated Sep 29HGH Fragment 176-191Sold as 'HGH frag' for fat loss. Human trials of this exact fragment: zero; its cousin AOD-9604 failed.Evidence · Animal onlyResearch only
- LongevityUpdated Sep 29MOTS-cSold as exercise in a bottle. Mice ran longer; human trials of injected MOTS-c: zero.Evidence · Animal onlyNot legal yet
- Fat lossUpdated Sep 28Nesfatin-1Studied since 2006 as an appetite brake. It has never been given to a person in a trial.Evidence · Animal onlyResearch only
- Fat lossUpdated Sep 29SLU-PP-332Sold as exercise in a pill. The evidence: one 2023 mouse paper where mice ran 70% farther.Evidence · Animal onlyResearch only
- Fat lossUpdated Sep 29SR9009Sold online as exercise in a pill. The fat loss came from mice injected for 30 days; no human trial.Case report: liver failure, transplantEvidence · Animal onlyResearch only
Muscle & growth hormone 17
- Muscle & growth hormoneUpdated Sep 28HGHAnti-aging clinics sell it for body composition. That story began with 12 men in a 1990 study.Evidence · Approved drugFDA approved
- Muscle & growth hormoneUpdated Sep 29TesamorelinApproved for HIV-related belly fat; clinics use it off-label. Its 412-patient trial cut belly fat 15–18%.Evidence · Approved drugFDA approved
- Hormones & libidoUpdated Sep 29TestosteronePrescribed for low testosterone; also the original anabolic steroid. Normal is 300–1,000 ng/dL.Evidence · Approved drugFDA approved
- Fat lossUpdated Sep 29BimagrumabPitched as fat loss that keeps muscle. Alone, it took off less weight than semaglutide in a 507-adult trial.Evidence · Human trialsResearch only
- Muscle & growth hormoneUpdated Sep 28GHRP-2Clinic users inject it 2–3 times a day. Its only approval: a one-shot growth-hormone test in Japan, 2004.Evidence · Human trialsResearch only
- Muscle & growth hormoneUpdated Sep 29MK-677Taken nightly for growth hormone and sleep. A year-long trial: +1.1 kg lean mass, no strength gain.Trial halted over heart failureEvidence · Human trialsResearch only
- Muscle & growth hormoneUpdated Sep 28SermorelinThe first FDA-approved growth-hormone releaser, now compounded for adults. The approval was for kids, 1997.Evidence · Human trialsCompounding pharmacy
- Muscle & growth hormoneUpdated Sep 28CJC-1295Anti-aging clinics pair it with ipamorelin for growth hormone. Human data: 57 people in two Phase 1 trials.Evidence · Human pilotsResearch only
- Muscle & growth hormoneUpdated Sep 28GHRP-6The 1984 original, now taken mostly for its hunger kick. Four decades of human data: dozens of small studies.Evidence · Human pilotsResearch only
- Muscle & growth hormoneUpdated Sep 29HexarelinKnown for the biggest growth-hormone pulse of its family. The catch: it fades within 2–4 weeks of daily use.Evidence · Human pilotsResearch only
- Muscle & growth hormoneUpdated Sep 28IpamorelinSold as the polite growth-hormone releaser that spares cortisol. That claim traces to a 1998 study in pigs.Evidence · Human pilotsResearch only
- Muscle & growth hormoneUpdated Sep 29Follistatin-344Bodybuilders buy vials to lift the body's muscle brake. Controlled human trials of vial follistatin: zero.Evidence · Animal onlyResearch only
- Muscle & growth hormoneUpdated Sep 29IGF-1 DESBodybuilders inject it into a muscle for 'spot growth'. Human studies of it: zero; it lasts 20–30 minutes.Evidence · Animal onlyResearch only
- Muscle & growth hormoneUpdated Sep 28IGF-1 LR3Taken by advanced lifters as an all-day muscle signal. Randomized human trials of this version: zero.Evidence · Animal onlyResearch only
- Muscle & growth hormoneUpdated Sep 28MGFLifters inject it into a muscle right after training. Human trials: zero; it lasts 5–7 minutes.Evidence · Animal onlyResearch only
- Muscle & growth hormoneUpdated Sep 28PEG-MGFLonger-lasting MGF, taken with BPC-157 or TB-500 by strength crowds. Human trials: zero.Evidence · Animal onlyNot legal yet
- Muscle & growth hormoneUpdated Sep 29FLGR-242A codenamed follistatin, sold by the company its promoter co-founded. Published studies of it: zero.Evidence · No dataResearch only
Tendon & gut repair 6
- Tendon & gut repairUpdated Sep 29BPC-157Every stubborn-injury guy keeps one in the fridge. 544 papers so far, almost all of them in rats.Evidence · Human pilotsNot legal yet
- Tendon & gut repairUpdated Sep 29CartalaxTaken in Khavinson cycles for the joints. The evidence: rat cartilage cells in a dish, zero human trials.Evidence · Animal onlyResearch only
- ImmuneUpdated Sep 28KPVTaken for gut and skin flares. Its best evidence: two 2008 mouse-colitis papers; human trials: zero.Evidence · Animal onlyNot legal yet
- Tendon & gut repairUpdated Sep 29TB-500Injected for tendons alongside BPC-157. What's sold is a 7-amino-acid fragment with zero human studies.Evidence · Animal onlyNot legal yet
- Tendon & gut repairUpdated Sep 29BPC-157 FragmentSold as a cheaper cut of BPC-157. Peer-reviewed studies of the fragment itself: zero.Evidence · No dataResearch only
- Tendon & gut repairUpdated Sep 29Pentadeca ArginateClinics sell it as the new BPC for injuries. Peer-reviewed studies of it: 0.Evidence · No dataResearch only
Skin & hair 22
- Skin & hairUpdated Sep 29Melanotan ITanners inject the gray-market version. The approved one is a 16 mg implant for a rare sun allergy.Evidence · Approved drugFDA approved
- Skin & hairUpdated Sep 28MatrixylIn hundreds of anti-aging serums. Its one good independent trial: 93 women, 12 weeks, modest gains.Evidence · Human trialsResearch only
- Skin & hairUpdated Sep 28ArgirelineSold as Botox in a jar. FDA researchers found about 0.22% of it reaches living skin.Evidence · Human pilotsResearch only
- Skin & hairUpdated Sep 28Decapeptide-12Sold in creams for melasma and dark spots. Its best trial: five women, one split-face study.Evidence · Human pilotsResearch only
- Skin & hairUpdated Sep 29GHK-CuSold in serums and injected off-label for hair. Its human trials: 12-week face creams, not injections.Evidence · Human pilotsNot legal yet
- LongevityUpdated Sep 28GlutathioneSold as an IV drip at wellness clinics. Its best trial: 54 adults, oral doses, body stores up over 6 months.Evidence · Human pilotsCompounding pharmacy
- Hormones & libidoUpdated Sep 28Melanotan IIInjected for a sunless tan and a libido kick. The tanning trial behind it had 3 people, in 1996.Mole changes in case reportsEvidence · Human pilotsNot legal yet
- Skin & hairUpdated Sep 28Pentapeptide-18Sold in wrinkle serums with Argireline. Its one open-label study: 11.31% shallower wrinkles in 28 days.Evidence · Human pilotsResearch only
- Skin & hairUpdated Sep 28AHK-CuSold in hair-growth serums as GHK-Cu's scalp cousin. The whole case rests on one 2007 lab paper.Evidence · Animal onlyResearch only
- Skin & hairUpdated Sep 28GHK BasicGHK-Cu without the copper, for creams that also carry vitamin C. Randomized human trials of it: zero.Evidence · Animal onlyResearch only
- ImmuneUpdated Sep 28KPVTaken for gut and skin flares. Its best evidence: two 2008 mouse-colitis papers; human trials: zero.Evidence · Animal onlyNot legal yet
- Skin & hairUpdated Sep 28Nonapeptide-1Sold in brightening creams at 1–2%. Independent human trials: zero; the data are the maker's.Evidence · Animal onlyResearch only
- Skin & hairUpdated Sep 28Pal-GHKHalf of the Matrixyl 3000 combo. Its best evidence is a 93-woman trial of a different peptide.Evidence · Animal onlyResearch only
- Skin & hairUpdated Sep 28RiginHalf of Matrixyl 3000, sold as anti-inflammaging. Trials of Rigin alone: zero; the data are the supplier's.Evidence · Animal onlyResearch only
- Skin & hairUpdated Sep 28SNAP-8Sold as a stronger Argireline in eye creams. Its data: the maker's own studies, 4% over 28 days.Evidence · Animal onlyResearch only
- Skin & hairUpdated Sep 28Syn-AkeSold as a snake-venom answer to Botox, at 1–4% in creams. Peer-reviewed trials: zero.Evidence · Animal onlyResearch only
- Skin & hairUpdated Sep 28Syn-CollUsed at 2–4% in serums to push collagen. The claims come from supplier studies; independent trials: zero.Evidence · Animal onlyResearch only
- Skin & hairUpdated Sep 28Tripeptide-29Sold in creams as the core of collagen, at 1–5%. Trials of creams with it as the active: zero.Evidence · Animal onlyResearch only
- Skin & hairUpdated Sep 28VialoxSold as a Botox alternative. Its '49% wrinkle reduction' is a supplier figure; peer-reviewed trials: zero.Evidence · Animal onlyResearch only
- Skin & hairUpdated Sep 29Waglerin-1A lethal pit-viper neurotoxin, studied in labs. Wrinkle creams use a small mimic; human trials: zero.Lethal snake-venom neurotoxinEvidence · Animal onlyResearch only
- Skin & hairUpdated Sep 28Pal-AHKUsed in hair serums at 0.5–2%. Peer-reviewed trials of this copper-free version: zero.Evidence · No dataResearch only
- Skin & hairUpdated Sep 28Palmitoyl Dipeptide-6Sold in firming serums at 1–4%. Peer-reviewed trials: zero; the claims come from supplier dossiers.Evidence · No dataResearch only
Mind & sleep 16
- Mind & sleepUpdated Sep 29BromantaneRussian doctors prescribe it for burnout and fatigue. Every trial so far is Russian; WADA banned it in 1997.Evidence · Human trialsResearch only
- Mind & sleepUpdated Sep 28DSIPInjected before bed for deeper sleep. A 1992 double-blind insomnia trial called it 'not likely' to help.Evidence · Human trialsResearch only
- Mind & sleepUpdated Sep 29OxytocinSold as a nose spray for mood and bonding. Approved in 1962 for labor; the nasal-spray trials are split.Evidence · Human trialsFDA approved
- Mind & sleepUpdated Sep 29SelankA Russian nasal spray for anxiety, approved there in 2009. Every trial so far is Russian.Evidence · Human trialsResearch only
- Muscle & growth hormoneUpdated Sep 28IpamorelinSold as the polite growth-hormone releaser that spares cortisol. That claim traces to a 1998 study in pigs.Evidence · Human pilotsResearch only
- Mind & sleepUpdated Sep 29Methylene BlueBiohackers take drops for brain energy. Its one brain study: a single 280 mg dose, 26 people, in 2016.Evidence · Human pilotsFDA approved
- Mind & sleepUpdated Sep 29NoopeptSold in US supplements as a memory booster. 20 years on the Russian market; no placebo trial published.Evidence · Human pilotsResearch only
- Mind & sleepUpdated Sep 28PinealonUsed in Russia after brain injury and stacked by longevity fans. Its best study: a 72-patient Russian series.Evidence · Human pilotsResearch only
- Mind & sleepUpdated Sep 29SemaxA Russian stroke drug that biohackers spray for focus. Its key stroke trial had 30 patients, in 1997.Evidence · Human pilotsNot legal yet
- Brain & nervesUpdated Sep 29CortagenSold as a synthetic Cortexin, Russia's brain drug. Best result: rat nerves regrew 27% faster, in 2000.Evidence · Animal onlyResearch only
- Mind & sleepUpdated Sep 29DihexaSold as a memory-and-focus capsule. The 2014 paper behind the hype was retracted in April 2025.Evidence · Animal onlyNot legal yet
- Mind & sleepUpdated Sep 29FGLSold to nootropic buyers as a memory peptide. Its only published human study: a safety test in 24 men.Neuron loss in healthy young ratsEvidence · Animal onlyResearch only
- Mind & sleepUpdated Sep 28N-Acetyl SelankSold as a longer-lasting Selank. Trials of the capped version: zero.Evidence · Animal onlyResearch only
- Mind & sleepUpdated Sep 29N-Acetyl SemaxSold as a longer-lasting Semax. Trials of the capped version: zero; the parent has two Russian stroke trials.Evidence · Animal onlyResearch only
- Mind & sleepUpdated Sep 29P21Nootropic buyers order it for new brain cells. Fifteen papers, one lab, mice only; human trials: zero.Evidence · Animal onlyResearch only
- Mind & sleepUpdated Sep 28DS5A vendor-made nasal spray of Dihexa and Semax. Trials of the blend: zero, and the ratios vary by vendor.Evidence · No dataResearch only
Brain & nerves 6
- Brain & nervesUpdated Sep 29ARA-290Chased by people with small-fiber nerve pain. Two Phase 2 trials, 28 days each; no Phase 3 yet.Evidence · Human trialsResearch only
- Brain & nervesUpdated Sep 29CerebrolysinPig-brain extract for stroke recovery. 200 trials, 44 countries, zero FDA.Evidence · Human trialsResearch only
- Mind & sleepUpdated Sep 29NoopeptSold in US supplements as a memory booster. 20 years on the Russian market; no placebo trial published.Evidence · Human pilotsResearch only
- Mind & sleepUpdated Sep 28PinealonUsed in Russia after brain injury and stacked by longevity fans. Its best study: a 72-patient Russian series.Evidence · Human pilotsResearch only
- Mind & sleepUpdated Sep 29SemaxA Russian stroke drug that biohackers spray for focus. Its key stroke trial had 30 patients, in 1997.Evidence · Human pilotsNot legal yet
- Brain & nervesUpdated Sep 29CortagenSold as a synthetic Cortexin, Russia's brain drug. Best result: rat nerves regrew 27% faster, in 2000.Evidence · Animal onlyResearch only
Hormones & libido 13
- Hormones & libidoUpdated Sep 29ClomipheneMen take a women's fertility pill off-label to raise testosterone. Approved since 1967, for women only.Vision changes may be irreversibleEvidence · Approved drugFDA approved
- Hormones & libidoUpdated Sep 29HCGMen on testosterone use it to stay fertile. The standard 500 IU every-other-day dose comes from a 2005 study.Evidence · Approved drugFDA approved
- Hormones & libidoUpdated Sep 29HMGUrine-derived hormones men add to hCG to make sperm. FDA-approved only for women's IVF, 20 days max.Evidence · Approved drugFDA approved
- Hormones & libidoUpdated Sep 28Insulin8 million Americans need it for diabetes; some bodybuilders inject it for size. Misuse can kill.Hypoglycemia can be fatalEvidence · Approved drugFDA approved
- Hormones & libidoUpdated Sep 28PT-141Approved for women's low desire, used mostly off-label by men. The approval trials: 1,247 women, zero men.Evidence · Approved drugFDA approved
- Hormones & libidoUpdated Sep 29TestosteronePrescribed for low testosterone; also the original anabolic steroid. Normal is 300–1,000 ng/dL.Evidence · Approved drugFDA approved
- Hormones & libidoUpdated Sep 29TriptorelinBodybuilders use one shot to 'restart' testosterone. It's approved to shut testosterone off, within 3–4 weeks.Evidence · Approved drugFDA approved
- Hormones & libidoUpdated Sep 29Enclomiphene CitrateMen's clinics prescribe it to raise testosterone and keep fertility. The FDA turned it down in 2015.Evidence · Human trialsCompounding pharmacy
- Hormones & libidoUpdated Sep 29GonadorelinClinics swap it in for hCG on TRT. It lasts 2–10 minutes in the blood, and studies of that use are thin.Evidence · Human trialsCompounding pharmacy
- Hormones & libidoUpdated Sep 29KisspeptinClinics sell it as a TRT add-on. Its Phase 2 trials, from two hospital groups, never tested that.Evidence · Human trialsResearch only
- Hormones & libidoUpdated Sep 28Melanotan IIInjected for a sunless tan and a libido kick. The tanning trial behind it had 3 people, in 1996.Mole changes in case reportsEvidence · Human pilotsNot legal yet
- Hormones & libidoUpdated Sep 29TestagenUsed in Russia for falling testosterone. The evidence: rodents from one lab, plus small Russian case reports.Evidence · Animal onlyResearch only
- Hormones & libidoUpdated Sep 29ZuclomipheneClomiphene's other half, tested for hot flashes. Its only Phase 2 result is an unpublished interim readout.Evidence · Animal onlyResearch only
Longevity 20
- Muscle & growth hormoneUpdated Sep 28HGHAnti-aging clinics sell it for body composition. That story began with 12 men in a 1990 study.Evidence · Approved drugFDA approved
- LongevityUpdated Sep 29EpithalonRussia's longevity peptide, taken in 10-day courses. Its famous 266-person study tested the pineal extract.Evidence · Human pilotsNot legal yet
- LongevityUpdated Sep 28GlutathioneSold as an IV drip at wellness clinics. Its best trial: 54 adults, oral doses, body stores up over 6 months.Evidence · Human pilotsCompounding pharmacy
- LongevityUpdated Sep 29NAD+Clinics sell it by IV because levels halve between 20 and 60. The trials mostly tested pills, not drips.Evidence · Human pilotsCompounding pharmacy
- Mind & sleepUpdated Sep 28PinealonUsed in Russia after brain injury and stacked by longevity fans. Its best study: a 72-patient Russian series.Evidence · Human pilotsResearch only
- LongevityUpdated Sep 28SS-31Approved in 2025 for a rare mitochondrial disease. Off-label longevity use rests on Phase 2 data.Evidence · Human pilotsFDA approved
- ImmuneUpdated Sep 29ThymalinA calf-thymus extract used in Russia since 1982. Its famous 266-person aging study came from its developers.Evidence · Human pilotsResearch only
- LongevityUpdated Sep 29BronchogenLongevity fans take it in capsule cycles for the lungs. Randomized human trials: zero.Evidence · Animal onlyResearch only
- LongevityUpdated Sep 29CardiogenLongevity fans take it in 10–20 day cycles for the heart. Randomized human trials: zero.Evidence · Animal onlyResearch only
- LongevityUpdated Sep 29ChonlutenTaken with Bronchogen in Khavinson cycles for the airways. Randomized human trials: zero.Evidence · Animal onlyResearch only
- LongevityUpdated Sep 28FOXO4-DRISold to longevity buyers as a zombie-cell killer. Human data: none; one 2017 mouse paper started it.Evidence · Animal onlyResearch only
- LongevityUpdated Sep 29HumaninA mitochondrial peptide sold for longevity. Twenty years of cell and rodent work; human trials: zero.Evidence · Animal onlyResearch only
- LongevityUpdated Sep 29KlothoSold as the protein that made mice live longer. Tested on 18 old monkeys' memory; no published human study.Evidence · Animal onlyResearch only
- ImmuneUpdated Sep 29LivagenPitched for liver and immune support in Khavinson cycles. Good randomized human trials: zero.Evidence · Animal onlyResearch only
- LongevityUpdated Sep 29MOTS-cSold as exercise in a bottle. Mice ran longer; human trials of injected MOTS-c: zero.Evidence · Animal onlyNot legal yet
- LongevityUpdated Sep 28N-Acetyl-EpithalonEpithalon with chemical caps, sold as longer-lasting. Human studies of the capped version: zero.Evidence · Animal onlyResearch only
- LongevityUpdated Sep 29OvagenTaken for liver and gut support. One lab's research, zero human trials; nothing to do with ovaries.Evidence · Animal onlyResearch only
- LongevityUpdated Sep 28PancragenUsed in Russian clinics alongside diabetes care. The evidence: 20 years of Russian case series.Evidence · Animal onlyResearch only
- LongevityUpdated Sep 28VesugenSold for blood vessels; the identical 3-amino-acid Vesilute is sold for immunity. The evidence is Russian.Evidence · Animal onlyResearch only
- ImmuneUpdated Sep 28VilonTwo amino acids, sold for immune support and aging. Independent human trials: zero.Evidence · Animal onlyResearch only
Immune 10
- ImmuneUpdated Sep 29Thymosin Alpha-1Prescribed for hepatitis B in about 35 countries. Not approved in the US, and on no FDA compounding list.Evidence · Human trialsResearch only
- ImmuneUpdated Sep 28ThymagenTwo amino acids, sold in Moscow pharmacies as Thymogen for immunity. Western randomized trials: zero.Evidence · Human pilotsResearch only
- ImmuneUpdated Sep 29ThymalinA calf-thymus extract used in Russia since 1982. Its famous 266-person aging study came from its developers.Evidence · Human pilotsResearch only
- ImmuneUpdated Sep 28ThymulinA zinc-charged thymus hormone, often confused with Thymalin. 50 years of research, mostly in rodents.Evidence · Human pilotsResearch only
- ImmuneUpdated Sep 28KPVTaken for gut and skin flares. Its best evidence: two 2008 mouse-colitis papers; human trials: zero.Evidence · Animal onlyNot legal yet
- ImmuneUpdated Sep 29LivagenPitched for liver and immune support in Khavinson cycles. Good randomized human trials: zero.Evidence · Animal onlyResearch only
- ImmuneUpdated Sep 28LL-37Injected for immune support. Its roughly 10 small human trials tested it on leg ulcers, not in shots.Evidence · Animal onlyNot legal yet
- ImmuneUpdated Sep 28Neurokinin AInhaled in labs to tighten airways and test asthma drugs. Not a therapy: the 3 drugs in its family block it.Evidence · Animal onlyResearch only
- ImmuneUpdated Sep 28VilonTwo amino acids, sold for immune support and aging. Independent human trials: zero.Evidence · Animal onlyResearch only
- ImmuneUpdated Sep 28VIPSprayed up the nose for mold illness (CIRS). Two large Phase 3 trials for other uses failed.Evidence · Animal onlyCompounding pharmacy
Nothing here matches “”. Try the name printed on the vial, a trade name, or a shorter part of it.